The toxicological effects of zinc oxide nanoparticles (ZnO-NPs) are attracting increasing concern as the field of nanotechnology progresses. Although the literature suggests that toxicity of ZnONPs may be related to their dissolution, the mechanism for ZnO-NP perturbation of cytosolic zinc concentration ( 
The chemical compound zinc oxide (ZnO) is widely used in the manufacture of paints, coatings, and semiconductors. Exposure to ZnO is known to cause metal fume fever, characterized by dry cough, chills, aches, and fever. Metal fume fever is the most frequent acute respiratory ailment of welders (Blanc et al., 1993) , and although exposure to respirable fumes of manganese and other metals have been implicated in producing symptoms related to metal fume fever, ZnO is the most common and best-characterized cause (Kelleher et al., 2000; Meo and Al-Khlaiwi, 2003) . Inhalation of ZnO has been shown to obstruct pulmonary function in animals and to cause pulmonary impairment similar to that of metal fume fever in humans (Beckett et al., 2005; Fine et al., 1997) . Exposure of human broncho-alveolar carcinoma A549 cells to zinc oxide nanoparticles (ZnO-NPs) exhibits steeper dose-dependent cytotoxicity than is seen with other metal oxides (Lin et al., 2009) . NPs, with sizes below 100 nm, are extremely attractive materials for industrial use but have also brought new public health concerns because of their potential for negatively impacting human health and the fact that the mechanism for their action is unknown or less welldocumented. Thus, a mechanistic toxicological pathway for ZnO-NP effects on human health remains obscure.
The toxicological effects of dissolution of nanosized metals have attracted numerous scientific studies. Solubility of oxide NPs, such as silicon dioxide, influences their cytotoxicity in mammalian cell lines (Brunner et al., 2006) . Using recombinant bacteria as a zinc sensor, Heinlaan showed that the solubility of bulk ZnO, ZnO-NPs, and ZnSO 4 was related to their toxicity (Heinlaan et al., 2008) , and both ZnO and Zn 2þ have been demonstrated to induce oxygen radical formation in human neutrophils (Lindahl et al., 1998) . In 2008, Xia et al. (2008) measured the dissolution of ZnO in medium and buffer using Inductively Coupled Plasma-Mass Spectrometry to quantify Zn content and also measured intracellular ZnO and Zn 2þ levels by confocal microscopy, quantifying elevations in cytosolic Ca 2þ concentrations with the Ca 2þ -sensitive fluorescent dye, fluo-4. They propose that oxidative stress occurs via Ca 2þ , causing collapse of mitochondria membrane potential in the affected cells. In 2010, George et al. proposed that decreasing the ZnO dissolution rate could reduce toxicity of ZnO by slowing Zn 2þ release (George et al., 2010) . Together, these previous studies show that Zn 2þ is likely to play a critical role in the toxicity of ZnO-NPs. However, the precise mechanism for perturbation of cytosolic Zn 2þ concentration ([Zn 2þ ] c ) homeostasis following exposure to ZnO-NPs remains unclear.
Some contradictory data have been reported. Chemical investigations using equilibrium dialysis have demonstrated slow dissolution of ZnO-NPs in an aqueous medium at pH 7.6 (Franklin et al., 2007) . However, ZnO appears to react differently under different pH conditions, exhibiting extreme stability above pH 7.0, but much greater dissolution at lower pH. Differential toxic potency of ZnO-NPs compared with Zn 2þ has been reported by Zhu in zebrafish embryos (Zhu et al., 2008 (Zhu et al., , 2009 ). Thus, further study of [Zn 2þ ] c homeostasis under conditions of ZnO-NP exposure is critical and will enable us to determine whether the toxicity of ZnO-NPs is, in fact, due to their dissolution.
Zinc is an essential element for humans but has toxic effects on mammalian cells at elevated concentrations. Zn 2þ shares some common characteristics with Ca 2þ and plays crucial roles in cell survival, exemplified by the fact that Zn 2þ at low concentrations is vital for cellular metabolism and cell proliferation, yet at high concentrations Zn 2þ can cause cell death. Mitochondria serve as checkpoints and amplifiers in cell death pathways. Elevation of [Zn 2þ ] c can trigger breakdown of mitochondrial membrane potential, caspase activation, and cell apoptosis (Gazaryan et al., 2007; Link and von Jagow, 1995; Manev et al., 1997; Skulachev et al., 1967) . Recent availability of fluorescent dyes sensitive to Zn 2þ but not to Ca 2þ has enhanced our ability to selectively measure these cations. FluoZin-3, highly selective for Zn 2þ , has been used to measure [Zn 2þ ] c (Devinney et al., 2005; Gee et al., 2002) , and RhodZin-3 has been shown to effectively localize to mitochondria and to selectively bind Zn 2þ ; thus it can be used to detect changes in mitochondrial free Zn 2þ concentration ([Zn 2þ ] m , Sensi et al., 2003b) . Taking advantage of these tools, this study investigated both in vitro and in vivo changes in [Zn 2þ ] c and [Zn 2þ ] m following the treatment of two cultured human cell types (Jurkat and H1355) with ZnO-NPs or airway exposure (rats) to ZnO-NPs.
MATERIALS AND METHODS

Materials
Human leukemia Jurkat cells were purchased from Bioresource Collection and Research Center (Hsinchu, Taiwan). Human lung carcinoma H1355 cells and human leukemia Jurkat cells were purchased from American Type Culture Center (Manassas, VA). Sprague-Dawley (SD) rats were purchased from BioLAS Co. (Taipei, Taiwan). ZnO-NPs of two different sizes (one < 50 nm with surface area 10.8 m 2 /g and the other < 100 nm with surface area 15-25 m 2 /g) were purchased from Sigma-Aldrich Co. (St Louis, MO) for use in the in vitro assays. Dulbecco's Modified Eagle's Medium, fetal bovine serum (FBS), Minimal Essential Medium, and RPMI 1640 medium were purchased from Gibco-BRL (Gaithersburg, MD). DiOC 2 (3), FluoZin-3 AM, NewportGreen DCF diacetate, and RhodZin-3 AM were purchased from Invitrogen (Grand Island, NY). PhiPhiLux G1D2 was purchased from OncoImmunin Inc. (Gaithersburg, MD). KCl, NaCl, and other salts were obtained from Merck KGaA (Darmstadt, Germany).
In Vitro Study
Cell culture. Human leukemia Jurkat cells were cultured in RPMI 1640 medium supplemented with 10% FBS, pH 7.6, and were grown in a 5% CO 2 incubator at 37°C (Harnett et al., 1998) . Human lung carcinoma H1355 cells were cultured in RPMI 1640 medium supplemented with 5% FBS, pH 7.6, and were grown in a 5% CO 2 incubator at 37°C (Lin et al., 2004) . pH was maintained between 7.4 and 7.6 throughout the culture and treatment periods.
Characterization of NPs. For in vitro studies, stock suspensions (100mM) of ZnO-NPs of the different size classes were prepared in ultrapure Milli-Q water, loading buffer (pH 7.6), and culture media (pH 7.6). Each suspension was sonicated with an ultrasonicator (Branson 5510) for 0.5 h prior to exposure. Each stock solution was then serially diluted to yield various concentrations. Size characterization of ZnO-NP samples was obtained by size distribution analysis of high-resolution transmission electron microscopy (TEM) images and scanning electron microscopy (SEM) images. TEM samples were prepared as 1mM ZnO-NPs (size < 50 nm; 81.4 lg/ml in buffer, pH 7.5) suspension prepared as above. TEM images of ZnO-NP were taken on a TEM (Philips CM100). SEM samples were prepared as 1mM ZnO-NPs suspension prepared as above. SEM images of ZnO-NP were taken on a SEM (Nova NanoSEM 230). The size distribution and zeta potential of ZnO-NPs (size < 50 nm, 81.4 lg/ml, pH 7.63 and size < 100 nm, 81.4 lg/ml, pH 7.62) in RPMI medium were measured via dynamic light scattering (DLS, Malvern Zetasizer Nano-ZS, Malvern, U.K.) at 25°C.
Cytosolic free zinc concentration ([Zn 2þ ] c ) measurements. Jurkat cells were treated with ZnO-NPs (< 50 nm), having100lM particles added each day for three consecutive days (medium completely exchanged with each addition). H1355 cells were treated with ZnO-NPs (size < 50 nm) for 30 min. After treatment, cells (5 3 10 6 cells/ml) were loaded with 10lM FluoZin-3 or Newport-Green DCF at 37°C for 40 min. Cells were then washed twice with a loading buffer containing 150mM NaCl, 5mM KCl, 5mM glucose, 1mM MgCl 2 , 2.2mM CaCl 2 , and 10mM 4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid, pH 7.4. For Newport-Green DCF detection, fluorescence intensities were measured at 505 nm excitation and 535 nm emission and for FluoZin-3 at 494 nm excitation and 515 nm emission. All fluorescence measurements were taken using a fluorometer (SPEX, CM system). Cytosolic (intracellular) free zinc ion concentration ([Zn 2þ ] c ) was calculated using the manufacturer-recommended equation: [Zn 2þ ]
F max (maximal fluorescence intensity where all dye is bound by zinc ions) was achieved by adding 0.01% digitonin and 0.1mM Zn 2þ to a cuvette at the end of each experiment; excess ethylene glycol tetraacetic acid (EGTA) was subsequently added to obtain F min (minimal fluorescence intensity where no dye is bound by zinc ions 
. F max was achieved by adding 0.01% digitonin and 0.1mM Zn 2þ to a cuvette at the end of each experiment; excess EGTA was subsequently added to obtain F min . A K d value of 65nM Zn 2þ was used for RhodZin-3.
Lactic dehydrogenase release assay. The lactic dehydrogenase (LDH) release assay was modified from the study of Jiang et al. (2009) . Briefly, cells were plated in 24-well plates on the day before the experiments. After treatment regime, supernatant containing LDH that has leaked from cells was collected from each well and set aside. Cells were then exposed to lysis buffer (9% Triton X-100) in order to obtain samples for intracellular LDH measurement. Following incubation for 30 min at room temperature, supernatants and cell lysates were separately subjected to the LDH assay. The extent of reduction of tetrazolium salt to a red formazan salt served as a measure of LDH activity. Absorbance was measured at 490 nm (A 490 ), with a reference wavelength of 690 nm. Results are expressed as percent released of total (supernatant À released LDH/[supernatant À released LDH þ LDH from lysed cells] 3 100).
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Caspase-3 activity detection. The caspase-3 activity of cells was measured using the PhiPhiLux G1D2 kit. A substrate of PhiPhiLux, G1D2, which can penetrate the plasma membrane, is converted to its fluorescent form when cleaved by the protease activity of caspase-3. The assay was performed according to the manufacturer's recommendations, with some modifications. Briefly, cells were incubated with PhiPhiLux G1D2 for 1 h at 37°C in 5% CO 2 and then double stained with propidium iodide (PI) for 15 min at 37°C. Caspase-3 activity and PI staining were measured by flow cytometry (Beckman, FC500).
Mitochondrial membrane potential (W m ) detection. JC-1 staining was carried out according to the manufacturer's instructions with modifications of Zhuang et al. (2008) . Cells were collected, washed in PBS, and then incubated in 10 lg/ml JC-1 for 15 min at 37°C and washed again in PBS. Stained cells were analyzed by flow cytometry (Beckman, FC500).
Zn-NP Generation and Rat Exposure (In Vivo Study)
ZnO particles were produced by a particle-generation system. This system creates particles using an evaporation-coagulation mechanism, similar to the ZnO fume generator described by Fine et al. (1997) . ZnO-NPs were generated from zinc powder heated to 570-600°C in a ceramic crucible furnace. ZnO vapor was produced by zinc vapor reacting with oxygen in high purity nitrogen gas. Before entering the major exposure chamber, ZnO vapors were mixed with filtered air in a series of cooling, humidifying, and diluting zones. Particle number, distribution, and concentration were monitored by a Scanning Mobility Particle Sizer and Condensation Particle Counter in the major exposure chamber (Fig. 7) . For the rodent study, 8-week-old male SD rats were used after 1 week acclimatization to a 12-h light/dark cycle, 23 ± 1°C, and 55 ± 10% humidity. Animals were randomly separated into two groups (six each), the high efficiency particulate air (HEPA)-control and ZnO-NP exposure group. Rats were housed in cages having a front tube connected to the major exposure chamber, either with (control group) or without (treated group) a HEPA airfilter. Rats were sacrificed using pentobarbital (50 mg/kg) 24 h after ZnO-NP exposure. Broncho-alveolar lavage (BAL) fluid and peripheral blood were collected from each animal. Our study was approved by the Institutional Animal Care and Use Committee at National Taiwan University.
BAL fluid was collected by washing the airway with a phosphate-buffered saline solution (PBS, pH 7.4, 28 ml/kg body weight). Lavage fluid was used for trypan blue cell counts by light microscopy to confirm cell viability. The collected BAL cells were loaded with Newport-Green DCF and FluoZin-3 to measure [Zn 2þ ] c (as described above). LDH activity in lavage fluid was measured using the lactate dehydrogenase reagents and assay described above.
White blood cells (WBC) were prepared from peripheral blood samples. 20 ml lysis buffer (62.5mM NH 4 Cl, 3.8mM Tris base, and 2.2mM EDTA, pH 7.2) was added to each 2 ml blood sample for 5-6 min, until the suspension became clear. Cells were washed twice in lysis buffer (centrifuged at 1000 3 g, 5 min). Finally, cells were resuspended in loading buffer and loaded with RhodZin-3. The experiments measuring [Zn 2þ ] m were carried out as described above.
Data Analysis
Each in vitro experiment was performed 3-6 times on separate cell batches and days. For in vivo studies, there were six rats in each group. All values are expressed as mean ± SD. Mean values were compared using Student's t-test; a p value less than 0.05 was considered significant. The exposed and unexposed rat data was analyzed using Kruskal-Wallis test (in SPSS). The R 2 and p values represent the relationship and significance among exposed and unexposed rat.
RESULTS
Particle Characterization
The commercially purchased NPs used for in vitro studies were characterized using DLS, zeta potential, TEM, and SEM, as described. Particle size of ZnO-NP in buffer was determined by TEM and SEM (Fig. 1) . Greater than 95% of the ZnO-NP in buffer was determined to be < 50 nm. The average of particle diameter was 22.3 ± 5.1 nm (n ¼ 30) in TEM and 44.5 ± 13.5 nm in SEM. Distribution of particle size by intensity and volume using DLS is shown in Supplementary figures S1 and S2, respectively. Following suspension in medium, the ZnO-NPs (powder size < 50 nm) had an average diameter of 16.07 nm and zeta potential of À9.85 mV. Size distribution by intensity analysis demonstrated three peaks (diameter/intensity): 5.7 nm/30%, 25.2 nm/32%, and 255 nm/38%. For ZnO-NPs of < 100 nm suspended in medium, the average diameter was 90.70 nm and zeta potential À9.48 mV. Intensity analysis of size distribution again showed three peaks (diameter/intensity): 6.8 nm/13%, 60.9 nm/25%, peak three in 248 nm/61%. Thus, both preparations of ZnO-NP contained a high percentage of particles within nanometer range. The size distribution of ZnO vapor for the in vivo studies was characterized using a Scanning Mobility Particle Sizer and Condensation Particle Counter (Fig. 7) . The size distribution of ZnO-NPs in three separate exposures was: 11-140 nm with peak at 32.4 nm; 7-139 nm with peak at 42.6 nm; and 8-143 nm with peak at 39.2 nm. All measurements show that the main particle sizes are distributed within nanometer range.
In order to prove our hypothesis that ZnO-NPs may dissolute into Zn 2þ in endosomes, we measured the changes of [Zn under exposure to ZnO-NPs and we also observed the turbidity of ZnO-NPs solution in different pH (Supplementary figure  S3) . The ZnO-NPs solution changed from cloudy in pH 7.4 to clear in pH 5.5 (endosomal pH). We suggest that the disappeared particles were dissolved into zinc ion to support our hypothesis that ZnO-NPs may dissolute into Zn 2þ in endosomal pH. (Fig. 3) . Using Newport-Green DCF in Figure 3A , treatment with 1mM (81 lg/ml) ZnO-NPs (size < 50 nm) elevated [Zn 2þ ] c , 28.8-fold compared with untreated cells. Smaller ZnO-NPs (size < 50 nm) resulted in a greater rise in [Zn 2þ ] c than ZnO-NPs of larger (< 100 nm) size (data not shown). At 100lM (8.1 lg/ml), both < 50 and < 100 nm particle size classes resulted in significantly elevated [Zn 2þ ] c (p < 0.01) but induced only a 2.5-and 1.5-fold elevation, respectively. Figure 3B shows the changes in [Zn 2þ ] c measured using FluoZin-3, a highly Zn 2þ -sensitive dye. Pretreatment with ZnO-NPs induced an increase in [Zn 2þ ] c . At 10lM (0.8 lg/ml), ZnO-NPs (< 50 nm) significantly elevated [Zn 2þ ] c , 5.8-fold over controls ( Fig. 3B ; p < 0.05). The images of either FluoZin-3 or Newport-Green DCF show that the cytosolic fluorescences were at a higher level in ZnO-NPs-treated cells comparing with untreated (Supplementary figure S4) .
ZnO-NPs
Changes in [Zn 2þ ] m were measured using RhodZin-3. Data is shown in Figure 3C . ] m increased 6.6-fold (size < 50 nm, p < 0.01) and 6.5-fold (size < 100 nm, p ¼ 0.12, data not shown) compared with untreated controls.
ZnO-NPs Decrease W m in H1355 Cells
Influx of cations from the cytosol to mitochondria can change the W m and cause a sudden increase in mitochondrial membrane permeability, leading to release of cytochrome c and triggering the intrinsic apoptosis pathway (Brookes et al., 2004; Kroemer, 1999) . Depolarization of W m was examined using the fluorescent dye JC-1. CCCP, a proton ionophore, causing depolarization of W m was used as a positive control. Figure 4A shows the change in W m : red fluorescence decreased in ZnO-NP pretreated cells. Figure 4B shows that 200lM (16 lg/ml) ZnO-NPs caused a significant decrease in W m (p < 0.05). One millimolar (81 lg/ml) ZnO-NPs decreased W m to 53.8 ± 16.2% of untreated control. In order to understand the impact of mitochondrial dysfunction on the cells, LDH release and caspase-3 activities were measured in the following experiments. ] m . Data are expressed as mean ± SD. #, *, and **: p < 0.1, p < 0.05, and p < 0.01 significant difference between ZnO-NP-treated and control cells.
CYTOTOXICITY OF ZINC OXIDE NANOPARTICLES 465
ZnO-NPs Reduce Viability of H1355 Cells
In H1355 cells, LDH release was increased following ZnO-NP treatment in a dose-dependent and time-dependent manner (Fig. 5) . Hundred micromolar (8.1 lg/ml) ZnO-NPs, < 50 nm, induced significant LDH release (p < 0.05). Three-day treatment with ZnO-NPs caused higher LDH release than 1-day treatments at concentrations above 10lM (0.8 lg/ml). Smaller particles (< 50 nm, Fig. 5A ) induced higher LDH release than larger ones (< 100 nm, Fig. 5B ), especially at 81 lg/ml ZnO-NPs. In order to classify the toxicity of ZnO-NP, the cytotoxicity of bulk ZnO and ZnCl 2 were investigated. Bulk ZnO induced no significant change at the concentration from 0.081 to 81 lg/ml. In the case of ZnCl 2 , significant effects only occurred at 1mM (Fig. 5C ).
In order to confirm involvement of the intrinsic apoptosis pathway in H1355 cells, we used Phiphilux G1D2 to measure the effect of ZnO-NP treatment on caspase-3 activation. The proportion of cells having caspase-3 activity was greater in ZnO-NP-treated cells compared with controls (Fig. 6) . At 81-lg/ml treatment, there was an 11.2-fold increase in caspase-3 activity.
Elevated [Zn 2þ ] c in BAL and WBC From Rats Exposed to ZnO-NPs
In experiments measuring the effects of exposure to ZnONPs in SD rats, [Zn 2þ ] c in BAL cells were determined. Following exposure, BAL cells were collected and loaded with Newport-Green DCF for measurement of [Zn 2þ ] c (Fig. 8A) . [Zn 2þ ] c in BAL cells from exposed rats was 2.8-fold higher than for HEPA-control animals (p < 0.05). FluoZin-3 measurements confirmed the finding of [Zn 2þ ] c increase in BAL cells from exposed rats (Fig. 8B) , showing a 1.5-fold elevation compared with controls. Similarly, [Zn 2þ ] c of WBC from ZnO-NP-exposed rats was elevated 5.9-fold above HEPA-controls ( Fig. 8C ; p < 0.05). RhodZin-3 measurement of [Zn 2þ ] m in rat WBC, showed a 1.1-fold higher level in experimental animals compared with HEPA-controls (Fig. 8D) .
LDH Release in Rat BAL Fluid Is Elevated Following
Exposure to ZnO-NPs LDH activity was measured in BAL fluid from exposed and control rats. In the low-dose group, animals were exposed to ZnO-NPs of 34 nm at 5.3 3 10 5 particles/cm 3 for 5 h; in the high-dose group, rats were exposed to 25 nm particles at 4.1 3 10 6 particles/cm 3 for 10 h. Figure 9 shows that LDH was elevated in BAL fluid from all exposed rats. LDH activity was 4.1 and 6.9-fold higher in low-and high-exposure animals, respectively, compared with their HEPA-controls. The sub-G1 level of BAL cells collected from exposure rats was 1.88 ± 0.29 folds of BAL cells collected from HEPA-control rats.
The Kruskal-Wallis analysis shows that the LDH release level was significantly related to the surface area of ZnO-NPs with an R 2 value of 0.42, p < 0.01; significantly related to the mass of ZnO-NPs with an R 2 value of 0.41, p < 0.01; and significantly related to the particle number concentration of ZnO-NPs with an R 2 value of 0.36, p < 0.01.
DISCUSSION
Based on our in vitro and in vivo data, we propose a mechanical pathway of ZnO-NP exposure leading to cell damage via dissolution into zinc ions, as shown in Figure 10 . This proposed pathway is divided into two phases, reflecting cellular compartmentalization and changes in cytosol (phase I) and in mitochondria (phase II) during ZnO-NP invasion. Phase Figure 8 shows the dramatic changes in [Zn 2þ ] c for both BAL and WBC from rats exposed to ZnO-NPs, compared with HEPA-controls. Both our data, and that of others, strongly supports the existence of the phase I mechanical pathway. It is well known that ZnO dissolves under acid conditions. Intracellular vesicles maintain a lower pH via the H þ pump in the vesicular membrane, and intracellular endosomes have a pH close to 5. The dissolution rate of ZnO at pH 5 (endosomal) will therefore be higher than at either pH 7.2 (cytosolic) or 7.4 (extracellular). In 2008, Xia et al. (2008) measured labeled ZnO-NPs present in intracellular vesicles and reported data consistent with our proposal of endocytosis of ZnO-NPs in phase I. Transient receptor potential channels are Zn 2þ -permeable cation channels that play a critical role in cellular Zn 2þ homeostasis and in Zn 2þ -induced injury (Inoue et al., 2010; Tu et al., 2010) . These channels could provide a mechanism for Zn Figures 2 and 3 show ZnO-NP-induced elevation in [Zn 2þ ] m for Jurkat and H1355 cells, respectively. In addition to this in vitro evidence, we have obtained in vivo data using our rat model. In Figure 8 , it can be seen that WBC isolated from ZnO-NP-exposed rats had higher [Zn 2þ ] m than HEPAcontrols. In cultured human lung cells, loss of nW m , activation of caspase-3, and cell death data are shown in Figures 4-6 , respectively. Additional data from other laboratories concerning the effects of Zn 2þ on the permeability of mitochondrial membranes support our proposed pathway. In 1967, Brierley and Knight (1967) 468 KAO ET AL. transport chain (Dineley et al., 2003; Link and von Jagow, 1995; Skulachev et al., 1967) . In 1998, Lindahl observed that Zn 2þ bound to and stimulated PLA2, causing oxygen radical generation (Lindahl et al., 1998) . Loss of nW m induced by Zn 2þ was measured by Dinely et al. (2002 Dinely et al. ( , 2003 , and the same laboratory has also shown that mitochondrial generation of reactive oxygen species (ROS) can be induced by an elevation in [Zn 2þ ] c . In addition, Zn 2þ at high concentration has been shown to cause DNA fragmentation and to activate caspase-3 (Jimenez Del Rio and Velez-Pardo, 2004; Watjen et al., 2002) . Taken together, our data and that of other laboratories give solid support to the proposed steps in phase II of our mechanical toxicological pathway for ZnO-NPs.
Cations play vital roles in mitochondria, where they are known to modulate ATP synthesis and ROS generation. The singular importance of Ca 2þ is documented by numerous reports and reviews (Feissner et al., 2009) . Zn 2þ shares some common characteristics with Ca 2þ as a divalent cation and has been shown to act as a signal regulating neuronal function and to play a role in mitochondrial function (Capasso et al., 2005; Feissner et al., 2009; Pavon et al., 2009; Sensi et al., 1999; Xia et al., 2004) . Rapid Zn 2þ influx triggers ROS generation, DW m loss, mitochondrial dysfunction, caspase activation, and apoptosis Donadelli et al., 2009; Sensi et al., 2000 Sensi et al., , 2003a Sensi and Jeng, 2004; Zhang et al., 2004) . Our data also show that elevation in [Zn 2þ ] c and [Zn 2þ ] m is coupled with mitochondrial dysfunction, caspase activation, and eventual cell death. We postulate that elevation in [Zn 2þ ] c induced by ZnO-NP may well trigger subsequent cell damage.
The known roles of Zn 2þ in the cytotoxicity of ZnO-NPs have been noted above. Kelleher et al. (2000) in 2000 postulated that increase in Zn 2þ may be the critical step in stimulating oxygen radical generation by cells exposed to ZnO in the circulation. ZnO-NPs have been shown to decrease mitochondrial function (Jeng and Swanson, 2006) , and Luo et al. (2009) ] c increases in a dosedependent fashion following ZnO-NP exposure in both cultured human cell lines and in BAL cells from ZnO-NP-exposed rats. Together, these data strongly suggest that ZnO-NP toxicity results from the effects of their dissolution to Zn 2þ ions, and the data reported here give further evidence that ZnO-NPs can interfere with [Zn 2þ ] c homeostasis and lead to cell damage and death. ] m measurements of rat WBC using RhodZin-3. Data are expressed as mean ± SD. *: p < 0.05 significant difference between ZnO-NP-exposed and HEPA-control rats.
FIG. 9.
ZnO-NP exposure elevated LDH content in rat BAL fluid. Rats were exposed to ZnO-NPs (high dose [n ¼ 6]: 25 nm size at 4.1 3 10 6 particle numbers/ cm 3 , 23.2 mg/m 3 for 10 h; low dose [n ¼ 6]: 34 nm size at 5.3 3 10 5 particle numbers/cm 3 , 6.6 mg/m 3 for 5 h; and HEPA-control [n ¼ 6]), and BAL cells were collected. The data are expressed as mean ± SD. *: p < 0.05 significant difference between BAL fluids from ZnO-NP-exposed and HEPA-control rats.
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The Zn 2þ fluorescent dyes FluoZin-3 and RhodZin-3 have high sensitivity to Zn 2þ but not to Ca 2þ (Devinney et al., 2005; Gee et al., 2002; Sensi et al., 2003b) , whereas Ca 2þ -sensitive fluorescent dyes are widely known to bind not only Ca 2þ but also other metal ions, including Zn 2þ (Devinney et al., 2005; Dineley, 2007; Haase et al., 2009) . However, calcium ion sensitive dye Fura-2 has a 100-fold higher affinity for Zn 2þ over Ca 2þ (Grynkiewicz et al., 1985) , and Fluo-4 shows greater than 10-fold higher affinity for Zn 2þ (Haase et al., 2009 ] m play a critical role in activation of caspase, release of LDH and cell death, demonstrating that the elevated [Zn 2þ ] c is a crucial step in the toxicity of ZnO-NPs.
The serum zinc level reported for normal people is 0.88 ± 0.6 lg/ml (Nsonwu et al., 2006) . In a case report, the urine zinc concentration of a 26-year-old welder with metal fume fever was measured at 400 lg/ml on the 10th day of hospitalization (Anthony et al., 1978) . In our study, the concentrations of zinc oxide used were from 81 310 À3 to 81.4 lg/ml those below the urine concentration measured in the metal fume fever patient. We conclude that elevation in [Zn 2þ ] c is the critical event in the toxicological process of ZnO-NPs. Our study elucidates a mechanical toxicological pathway for ZnO-NP inhalation. Phase I initiates with endocytosis of ZnO-NPs, their dissolution in endosomes and a consequent increase in [Zn 2þ ] c . In phase II, mitochondria sequester cytosolic Zn 2þ , causing mitochondria membrane potential collapse, activating caspase-3 and resulting in cell apoptosis. ] m induces mitochondrial membrane potential collapse, which activates caspase-3 and leads to cell apoptosis (7) and LDH release (8). /: Welldocumented theory; --->: Theory supported by our data; and ÁÁÁÁÁ>: Our assumption. 470 KAO ET AL.
